One-year outcome of combination therapy with intravitreal aflibercept and photodynamic therapy for polypoidal choroidal vasculopathy

被引:0
|
作者
Hsin-Yu Weng
Tzu-Lun Huang
Pei-Yao Chang
Jia-Kang Wang
机构
[1] Far Eastern Memorial Hospital,Department of Ophthalmology
[2] Yuan Ze University,Department of electrical engineering
[3] National Taiwan University,Department of Medicine
[4] National Yang Ming University,Department of Medicine
[5] Oriental Institute of Technology,Department of Healthcare Administration and Department of Nursing
关键词
Intravitreal injection; Aflibercept; Photodynamic therapy; Polypoidal choroidal vasculopathy;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [1] One-year outcome of combination therapy with intravitreal aflibercept and photodynamic therapy for polypoidal choroidal vasculopathy
    Weng, Hsin-Yu
    Huang, Tzu-Lun
    Chang, Pei-Yao
    Wang, Jia-Kang
    BMC PHARMACOLOGY & TOXICOLOGY, 2019, 20 (1):
  • [2] One-year outcome of combination therapy with intravitreal aflibercept and verteporfin photodynamic therapy for polypoidal choroidal vasculopathy
    Wataru Matsumiya
    Shigeru Honda
    Keiko Otsuka
    Akiko Miki
    Takayuki Nagai
    Hisanori Imai
    Sentaro Kusuhara
    Makoto Nakamura
    Graefe's Archive for Clinical and Experimental Ophthalmology, 2017, 255 : 541 - 548
  • [3] One-year outcome of combination therapy with intravitreal aflibercept and verteporfin photodynamic therapy for polypoidal choroidal vasculopathy
    Matsumiya, Wataru
    Honda, Shigeru
    Otsuka, Keiko
    Miki, Akiko
    Nagai, Takayuki
    Imai, Hisanori
    Kusuhara, Sentaro
    Nakamura, Makoto
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2017, 255 (03) : 541 - 548
  • [4] Comparison of One-Year Outcome of Intravitreal Aflibercept with or without Photodynamic Therapy for Polypoidal Choroidal Vasculopathy
    Weng, Hsin-Yu
    Chen, Fang-Ting
    Wang, Ling-Uei
    Huang, Tzu-Lun
    Ho, Wei-Ting
    Chang, Pei-Yao
    Hsu, Yung-Ray
    Chen, Yun-Ju
    Wang, Jia-Kang
    MEDICINA-LITHUANIA, 2024, 60 (08):
  • [5] One-Year Outcome of Aflibercept and Photodynamic Therapy in a Caucasian Patient with Polypoidal Choroidal Vasculopathy Refractory to Ranibizumab and Photodynamic Therapy
    Medina-Baena, Marta
    Jesus Huertos-Carrillo, Maria
    Rodriguez, Laura
    Ignacio Garcia-Pulido, Juan
    Cornejo-Castillo, Carlos
    Maria Calandria-Amiguetti, Jose
    CASE REPORTS IN OPHTHALMOLOGY, 2018, 9 (01): : 172 - 178
  • [6] Comparison of Two-Year Outcome of Photodynamic Therapy in Combination with Intravitreal Aflibercept or Ranibizumab for Polypoidal Choroidal Vasculopathy
    Weng, Hsin-Yu
    Huang, Tzu-Lun
    Chang, Pei-Yao
    Ho, Wei-Ting
    Hsu, Yung-Ray
    Chen, Fang-Ting
    Chen, Yun-Ju
    Wang, Jia-Kang
    APPLIED SCIENCES-BASEL, 2021, 11 (03): : 1 - 9
  • [7] ONE-YEAR RESULTS OF INTRAVITREAL AFLIBERCEPT FOR POLYPOIDAL CHOROIDAL VASCULOPATHY
    Hara, Chikako
    Sawa, Miki
    Sayanagi, Kaori
    Nishida, Kohji
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2016, 36 (01): : 37 - 45
  • [8] One-Year Results of Intravitreal Aflibercept for Polypoidal Choroidal Vasculopathy
    Yamamoto, Akiko
    Okada, Annabelle A.
    Kano, Mariko
    Koizumi, Hideki
    Saito, Masaaki
    Maruko, Ichiro
    Sekiryu, Tetsuju
    Iida, Tomohiro
    OPHTHALMOLOGY, 2015, 122 (09) : 1866 - 1872
  • [9] One-Year Results of Intravitreal Ranibizumab with or without Photodynamic Therapy for Polypoidal Choroidal Vasculopathy
    Song, Min-Hye
    Ryu, Hyun-Wook
    Roh, Young-Jung
    OPHTHALMOLOGICA, 2011, 226 (03) : 119 - 126
  • [10] Comparison of one-year results of photodynamic therapy combined with ranibizumab or aflibercept for treating polypoidal choroidal vasculopathy
    Ito, Arisa
    Maruyama-Inoue, Maiko
    Kitajima, Yoko
    Sato, Shimpei
    Inoue, Tatsuya
    Yamane, Shin
    Kadonosono, Kazuaki
    PLOS ONE, 2020, 15 (06):